Study shows new COVID target could improve vaccines
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
Chikungunya antibody identified at VUMC moves forward
VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody
Vanderbilt University Medical Center’s Crowe receives 2020 “Golden Goose” Award for COVID-19 research
VUMC and AstraZeneca join forces to identify potential COVID-19 treatments
Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center.
Antibody mixture may help block Ebola virus infection
An antibody isolated by James Crowe's lab found to halt the human dengue virus.
New tool may speed antibody, vaccine research